Ajenat Pharmaceuticals, LLC
FDA 503B outsourcing facility
Largo, Florida
Key Takeaways
- FDA-registered 503B outsourcing facility since 2025
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- March 26, 2025
- Most recent registration
- November 26, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
Ajenat Pharmaceuticals, LLC has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
Ajenat Pharmaceuticals, LLC has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
6911 Bryan Dairy Rd, Largo, FL 33777
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Supriya Taneja, 1-727-506-1261. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Ajenat Pharmaceuticals, LLC with the Florida Board of Pharmacy.
503B facilities in Florida
Florida has 16 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Florida.
Frequently asked questions
Is Ajenat Pharmaceuticals, LLC registered with the FDA?
Yes. Ajenat Pharmaceuticals, LLC is a registered 503B outsourcing facility, first registered with the FDA on March 26, 2025 and most recently registered on November 26, 2025.
Has Ajenat Pharmaceuticals, LLC been inspected by the FDA?
Ajenat Pharmaceuticals, LLC has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has Ajenat Pharmaceuticals, LLC had any FDA drug recalls?
No FDA drug recalls are matched to Ajenat Pharmaceuticals, LLC in the openFDA enforcement database.
What does Ajenat Pharmaceuticals, LLC compound?
Ajenat Pharmaceuticals, LLC has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Ajenat Pharmaceuticals, LLC located?
Ajenat Pharmaceuticals, LLC is located in Largo, Florida (6911 Bryan Dairy Rd).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Ajenat Pharmaceuticals, LLC. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.